Drug Shortage Report for SANDOZ MONTELUKAST

Last updated on 2018-05-23 History
Report ID 44744
Drug Identification Number 02328593
Brand name SANDOZ MONTELUKAST TABLET
Common or Proper name MONTELUKAST
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) MONTELUKAST
Strength(s) 10MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100 TABLETS
ATC code R03DC
ATC description OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
Reason for shortage Requirements related to complying with good manufacturing practices.
Anticipated start date
Actual start date 2018-03-23
Estimated end date 2018-05-18
Actual end date 2018-05-11
Shortage status Resolved
Updated date 2018-05-23
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2018-05-23 French Compare
v5 2018-05-23 English Compare
v4 2018-05-07 French Compare
v3 2018-05-07 English Compare
v2 2018-04-03 French Compare
v1 2018-04-03 English Compare

Showing 1 to 6 of 6